Kevin J. Harrington
Publications by Year
Research Areas
Head and Neck Cancer Studies, Virus-based gene therapy research, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cancer Research and Treatments
Most-Cited Works
- → Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck(2016)4,969 cited
- → Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study(2019)3,089 cited
- → Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma(2015)2,541 cited
- → The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence(2015)2,081 cited
- → Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial(2011)1,665 cited
- → Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study(2018)1,656 cited